RIGOTTI, PAOLO
 Distribuzione geografica
Continente #
NA - Nord America 407
EU - Europa 54
AS - Asia 9
SA - Sud America 5
AF - Africa 3
OC - Oceania 1
Totale 479
Nazione #
US - Stati Uniti d'America 403
IT - Italia 33
BR - Brasile 5
RU - Federazione Russa 5
CA - Canada 4
CN - Cina 3
NL - Olanda 3
ZA - Sudafrica 3
CZ - Repubblica Ceca 2
FI - Finlandia 2
FR - Francia 2
GB - Regno Unito 2
GR - Grecia 2
JP - Giappone 2
AU - Australia 1
DE - Germania 1
IN - India 1
KR - Corea 1
LT - Lituania 1
NP - Nepal 1
RO - Romania 1
TR - Turchia 1
Totale 479
Città #
Fairfield 61
Santa Cruz 34
Houston 33
Seattle 29
Ashburn 28
Padova 26
Cambridge 24
Woodbridge 18
Buffalo 14
Ann Arbor 13
Des Moines 12
Wilmington 9
Chicago 8
San Diego 8
Cotia 5
Los Angeles 4
Muizenberg 3
Saint Petersburg 3
Bergamo 2
Dallas 2
Helsinki 2
Henderson 2
Lombard 2
Ottawa 2
San Francisco 2
Athens 1
Auburn 1
Bengaluru 1
Boardman 1
Clearwater 1
Council Bluffs 1
Crugers 1
Denver 1
Dulles 1
Fujita 1
Guangdong 1
Herndon 1
Jawalakhel 1
Lake Forest 1
Lanzhou 1
Las Vegas 1
Mosman 1
Mountain View 1
Paris 1
Phoenix 1
Portland 1
Provo 1
Redmond 1
Richmond 1
San Jose 1
Shanghai 1
Springfield 1
Toronto 1
Tucson 1
Washington 1
Totale 376
Nome #
Deceased donor-initiated Chains: first report of a successful deliberate case and its ethical implications, file e14fb26b-56ec-3de1-e053-1705fe0ac030 174
Correction to: Effects of immune suppression for transplantation on inflammatory colorectal cancer progression (Oncogenesis, (2018), 7, 6, (46), 10.1038/s41389-018-0055-5), file e14fb26b-721a-3de1-e053-1705fe0ac030 112
Increased cancer risk in patients undergoing dialysis: a population-based cohort study in North-Eastern Italy, file e14fb26b-8654-3de1-e053-1705fe0ac030 77
Safety and efficacy of eculizumab for the prevention of antibody-mediated rejection after deceased-donor kidney transplantation in patients with preformed donor-specific antibodies, file e14fb26e-f36e-3de1-e053-1705fe0ac030 38
MicroRNA 193b-3p as a predictive biomarker of chronic kidney disease in patients undergoing radical nephrectomy for renal cell carcinoma, file e14fb26f-9378-3de1-e053-1705fe0ac030 37
Immune activation, immune senescence and levels of Epstein Barr Virus in kidney transplant patients: Impact of mTOR inhibitors, file e14fb26f-1c05-3de1-e053-1705fe0ac030 34
Efficacy and safety of tacrolimus compared with ciclosporin-A in renal transplantation: 7-Year observational results, file e14fb26f-96e2-3de1-e053-1705fe0ac030 10
Alefacept Combined With Tacrolimus, Mycophenolate Mofetil and Steroids in De Novo Kidney Transplantation: A Randomized Controlled Trial., file e14fb267-a669-3de1-e053-1705fe0ac030 5
Early activation of fibrogenesis in transplanted kidneys: a study on serial renalbiopsies, file e14fb269-42d1-3de1-e053-1705fe0ac030 5
Plasma exchange in a patient with primary antiphospholipid syndrome undergoing kidney transplantation, file e14fb267-8d75-3de1-e053-1705fe0ac030 3
Calcimimetic and vitamin D analog use in hemodialyzed patients is associated with increased levels of vitamin K dependent proteins, file e14fb268-8fd6-3de1-e053-1705fe0ac030 3
Immune activation, immune senescence and levels of Epstein Barr Virus in kidney transplant patients: Impact of mTOR inhibitors, file e14fb26c-39f1-3de1-e053-1705fe0ac030 3
Comparison of CMV ELISPOT and CMV Quantiferon™ interferon-γ releasing assays in assessing risk of CMV infection in kidney transplant recipients., file e14fb267-a66a-3de1-e053-1705fe0ac030 2
Evaluation of cytomegalovirus (CMV)-specific T cell immune reconstitution revealed that baseline antiviral immunity, prophylaxis, or preemptive therapy but not antithymocyte globulin treatment contribute to CMV-specific T cell reconstitution in kidney transplant recipients., file e14fb267-88d8-3de1-e053-1705fe0ac030 1
A single-center experience with 200 dual kidney transplantations., file e14fb267-b4d2-3de1-e053-1705fe0ac030 1
Outcome and quality of life of patients with augmented bladder or urinary diversion after kidney transplantation, file e14fb26e-9d8d-3de1-e053-1705fe0ac030 1
Totale 506
Categoria #
all - tutte 905
article - articoli 905
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1810


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/20181 0000 00 00 0010
2018/201912 0020 00 00 0136
2019/202050 3212 51 58 9554
2020/2021116 3513 24 59 634404
2021/2022206 11131025 335 1715 1264415
2022/2023117 1663826 715 72 0000
Totale 506